Currently out of the existing stock ratings of Amy Li, 9 are a BUY (100%).

Amy Li

Work Performance Price Targets & Ratings Chart

Analyst Amy Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 50% that have a potential upside of 27.54% achieved within 89 days.

Amy Li’s has documented 18 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SRRK, Scholar Rock Holding Corp at 15-Sep-2026.

Wall Street Analyst Amy Li

Analyst best performing recommendations are on LQDA (LIQUIDIA TECHNOLOGIES).
The best stock recommendation documented was for LQDA (LIQUIDIA TECHNOLOGIES) at 11/3/2025. The price target of $45 was fulfilled within 92 days with a profit of $19.78 (78.43%) receiving and performance score of 8.52.

Average potential price target upside

BHVN Biohaven Pharmaceutical Holding Co Ltd IRWD Ironwood Pharmaceuticals LQDA Liquidia Technologies SRRK Scholar Rock Holding Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Dec-2025

$10

$-2.87 (-22.30%)

$10

29 days ago
(10-Sep-2026)

4/15 (26.67%)

$-2.79 (-21.81%)

23

Buy Since 03-Mar-2026

$19

$6.13 (47.63%)

$22

1 months 1 days ago
(08-Sep-2026)

0/16 (0%)

$4.28 (29.08%)

Buy Since 24-Jul-2024

$19

$6.13 (47.63%)

$21

1 months 27 days ago
(12-Aug-2026)

0/8 (0%)

$4.61 (32.04%)

Hold Since 29-Jun-2026

$11

$-1.87 (-14.53%)

$10

3 months 10 days ago
(29-Jun-2026)

1/5 (20%)

$-3.95 (-26.42%)

23

Buy Since 17-Sep-2025

$17

$4.13 (32.09%)

$17

5 months 27 days ago
(12-Apr-2026)

1/4 (25%)

$7.83 (85.39%)

222

Show more analysts

Please expand the browser size to see the chart

Which stock is Amy Li most bullish on?

Potential upside of $18.19 has been obtained for SRRK (SCHOLAR ROCK HOLDING CORP)

What Year was the first public recommendation made by Amy Li?

On 2024
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?